Due to a production error, the latest version of Figure 3 was not published. The corrected Figure 3 appears below.
FIGURE 3
The publisher apologizes for this mistake. The original version of this article has been updated.
Summary
Keywords
resveratrol, ulcerative colitis, phosphoinositide 3-kinase, protein kinase B, vascular endothelial growth factor A
Citation
Frontiers Production Office (2021) Erratum: Resveratrol Alleviates Dextran Sulfate Sodium-Induced Acute Ulcerative Colitis in Mice by Mediating PI3K/Akt/ VEGFA Pathway. Front. Pharmacol. 12:797101. doi: 10.3389/fphar.2021.797101
Received
18 October 2021
Accepted
18 October 2021
Published
02 November 2021
Approved by
Frontiers Editorial Office, Frontiers Media SA, Switzerland
Volume
12 - 2021
Updates
Copyright
© 2021 Frontiers Production Office.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Frontiers Production Office, production.office@frontiersin.org
This article was submitted to Gastrointestinal and Hepatic Pharmacology, a section of the journal Frontiers in Pharmacology
Disclaimer
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.